Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-107A-01 in Post-Surgical Dental Pain
NCT04571515Phase 2Completed
- Sponsor
- Mylan
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of meloxicam in postoperative pain (5 arms), sponsored by Mylan. Primary endpoint: Summed Pain Intensity Difference at 24 hours. Started Sep 2020; status: completed.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04571515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04571515.